Study to treat front-line clinicians suffering COVID stress with psilocybin

A small study out of the University of Washington School of Medicine will assess if psilocybin-assisted psychotherapy can help alleviate depression and anxiety in healthcare workers who are working the front lines of the pandemic.

Story continues below

This advertisement has not loaded yet, but your article continues below.

The study will be led by Dr. Anthony Back, a professor of medicine and founding co-director of the University of Washington Center for Excellence in Palliative Care.

“We’re looking for doctors, nurses and advance-practice providers who have clinically significant symptoms of depression and anxiety. We hope to help them address their feelings of grief, inadequacy and moral distress as a result of caring for COVID patients,” Dr. Back said in

Read full article on The Growth Op